UNSPSC 51383305: Felbinac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H12O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94WNJ5U8L7, chemically known as ljc 10,141 but generally known as felbinac, which bears US NIH Compound Identifier 3332. European Medicines Agency schedules Felbinac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07527MIG.

UNSPSC 51383305 Felbinac, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities posted under this code involve naloxone and drug deactivation systems, direct-to-manufacturer pharmacy prescriptions, and generic multi-source pharmaceuticals and over-the-counter products — none of which represent felbinac, a topical nonsteroidal anti-inflammatory drug. The mismatch suggests either a classification error in the procurement data or incidental tagging that does not reflect genuine market activity in felbinac itself. No state or local solicitations for felbinac procurement appear in the recent opportunities block.

The code shows little actionable recent activity for vendors focused on felbinac specifically. Procurement professionals should verify whether the code's tagging reflects actual demand for this pharmaceutical or whether the data reflects a data-entry or system-classification issue at the posting source. If pursuing opportunities under this code, confirm with issuing bodies that their intent aligns with felbinac supply before investing in proposal development.